Targeting Neutrophils as effector cells in cancer therapy

December, 2022

About this episode

The fourth episode of “Immuno Oncology Talks”, Professor Marjolein van Egmond from the Amsterdam University Medical Center, in the Netherlands, will shed light on neutrophils as effector cells in cancer therapy. Professor Marjolein van Egmond specializes in the innate immune system and is focusing on elucidating the therapeutic potential of neutrophils in cancer, with a specific interest in IgA and bispecific antibodies to activate the neutrophils.


Related material

All episodes

Aristi Fernandes

Suggestions on future topics and experts?

Do you have suggestions on topics or experts you would like to be featured in the podcast?

Feel free to contact me - Aristi Fernandes, PhD. Medical Lead Oncology, North Europe

About the Immuno Oncology Talks Podcast

The “Immuno Oncology Talks” aims to shed light on cutting edge science that is evolving with new immunological therapeutic approaches for the treatment of cancers. The podcasts consist of discussions with leading experts and are intended for anyone that would like to broaden their knowledge of what is happening in this rapidly expanding field.